Indivior PLC (GBP)
INDV
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range0.83 | 0.92
52-Wk Range- | -
Last Close0.91
Mkt Cap (m)666.52
Dividend yield-
ISINGB00BRS65X63
Volume2,304,158.00
Exchange VenueLON

Company Profile

Indivior PLC is a US-based specialty and generic drug manufacturin eneric drug manufacturg company. The firm develops, manufactures, and sells prescription drugs that are mainly based on buprenorphine for treatment of opioid dependence.

Key Information
Price/Earning-
Price/Book21.32
Price/Sales1.23
P/CF-
Rev Growth (3 year avg)-9.47
EPS Growth (3 year avg)0.53
Operating Margin % 22.68
Net Margin %17.07
Return on Equity97.45
Debt/Equity1.40

Documents

Prospectus
en 17/11/2014
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

http://www.indivior.com

Financials

Income Statement
GBP201420152016201720182019
Revenue (m)1,115.001,014.001,058.001,093.001,005.00785.00
Operating Income (m)562.00346.00149.00193.00316.00178.00
Net Income (m)403.00228.0035.0058.00275.00134.00
Basic EPS0.560.320.050.080.380.18
Avg. Diluted Shares Outstanding (m)723.88733.09743.22748.48751.14755.36
Balance Sheet
GBP201420152016201720182019
Current Assets (m)565.00721.00990.001,225.001,329.001,360.00
Non Current Assets (m)182.00216.00219.00219.00218.00292.00
Total Assets (m)747.00937.001,209.001,444.001,547.001,652.00
Current Liabilities (m)462.00603.001,030.00854.00818.00742.00
Total Liabilities (m)------
Total Equity (m)-475.00-279.00-295.00-203.0066.00209.00
Cash Flows
GBP201420152016201720182019
Operating Cash Flows (m)440.00320.00407.00295.00303.00151.00
Capital Expenditure (m)-26.00-31.00-35.00-43.00-41.00-7.00
Figures are quoted in GBP unless stated otherwise
-
No change
£
0.91
Last Price